Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-Q Report Quarterly Report
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. UPLOAD Other SEC-generated Letter
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Executive or director change
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. PRE 14A Proxy Proxy Statement (Preliminary)
  10. 8-K Event Other events
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Material agreement
  14. 8-K Event Executive or director change
  15. SC 13G Stake Amended Statement of Ownership
  16. 424B5 Offering Prospectus
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 8-K Event Results of operations
  19. 10-K Report Annual Report
  20. 4 Derivatives Options or other derivatives

Page 21 of 41 · 801 filings